Reference
Bolin K, et al. The cost-effectiveness of growth hormone replacement therapy (Genotropin(R)) in hypopituitary adults in Sweden. Cost Effectiveness and Resource Allocation : 30 Sep 2013. Available from: URL: http://dx.doi.org/10.1186/1478-7547-11-24
Rights and permissions
About this article
Cite this article
Growth hormone: big gains at acceptable cost in Sweden. PharmacoEcon Outcomes News 689, 7 (2013). https://doi.org/10.1007/s40274-013-0792-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0792-9